Proton-pump inhibitors for acute peptic ulcer bleeding.

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Acute peptic ulcer bleeding is a significant clinical concern.
• Effective management strategies are crucial for improving patient outcomes.

Purpose of the Study:

• To review the efficacy of proton-pump inhibitors (PPIs) in managing acute peptic ulcer bleeding.
• To identify patient subgroups that benefit most from PPI therapy.

Main Methods:

• Comprehensive literature search of MEDLINE and relevant textbooks.
• Inclusion of randomized controlled trials and pharmacoeconomic evaluations of PPIs for peptic ulcer bleeding.
• Extraction of primary outcomes including bleeding recurrence, transfusion needs, interventions, length of stay, and mortality.

Main Results:

• Short-term, high-dose omeprazole significantly reduces bleeding and transfusion requirements in acute peptic ulcer bleeding.
• High-risk patients and those with delayed endoscopic evaluation show the greatest benefit.

Conclusions:

• Omeprazole and potentially other PPIs are valuable in managing acute peptic ulcer bleeding.
• Further research is needed to refine patient selection for optimal PPI therapy.